Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2022
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study
Yiqi Su, Anat Stern, Eleni Karantoni, et al.
Nutrients
|
August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study
Daniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Transplantation and Cellular Therapy
|
December 19, 2024
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients
Gyuri Han, Anat Stern, Yeon Joo Lee, et al.
Transplantation and Cellular Therapy
|
June 26, 2026
Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas
Niveen Shibli, Sigrun Einarsdottir, Teng Fei, et al.
Acta Haematologica
|
May 23, 2024
Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?
Mayasa Abu Ata, Israel Henig, Dana Yehudai-Ofir, et al.
The Journal of Antimicrobial Chemotherapy
|
July 29, 2021
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study
Anat Stern, Carolyn D Alonso, Carolina Garcia-Vidal, et al.
Plos One
|
November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
Adi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Antimicrobial Resistance and Infection Control
|
November 5, 2025
Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial
Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
Dafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Gerontology
|
October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia
Adi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2022
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study
Yiqi Su, Anat Stern, Eleni Karantoni, et al.
Nutrients
|
August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study
Daniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Transplantation and Cellular Therapy
|
December 19, 2024
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients
Gyuri Han, Anat Stern, Yeon Joo Lee, et al.
Transplantation and Cellular Therapy
|
June 26, 2026
Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas
Niveen Shibli, Sigrun Einarsdottir, Teng Fei, et al.
Acta Haematologica
|
May 23, 2024
Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?
Mayasa Abu Ata, Israel Henig, Dana Yehudai-Ofir, et al.
The Journal of Antimicrobial Chemotherapy
|
July 29, 2021
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study
Anat Stern, Carolyn D Alonso, Carolina Garcia-Vidal, et al.
Plos One
|
November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
Adi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Antimicrobial Resistance and Infection Control
|
November 5, 2025
Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial
Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
Dafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Gerontology
|
October 23, 2022
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia
Adi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Page
of 5